수의 순환기학 시장 예측(-2034년) : 제품 유형, 동물 유형, 적응증, 진단 방법, 치료법, 용도, 최종사용자, 판매 채널, 지역별 세계 분석

According to Stratistics MRC, the Global Veterinary Cardiology Market is accounted for $0.50 billion in 2026 and is expected to reach $1.01 billion by 2034 growing at a CAGR of 9.2% during the forecast period. Veterinary cardiology is a specialized branch of veterinary medicine focused on the diagnosis, treatment, and management of heart and circulatory system conditions in animals, including congenital heart defects, valvular diseases, cardiomyopathies, arrhythmias, and heart failure. The market encompasses diagnostic imaging systems, cardiac monitoring devices, therapeutic pharmaceuticals, surgical instruments, and interventional cardiology products. The market serves veterinary hospitals, clinics, specialty cardiology centers, and academic and research institutions through direct sales, distributors, online sales, and group purchasing organizations. Growing pet ownership, increasing prevalence of cardiac conditions in aging pets, rising demand for advanced cardiovascular care, and technological advancements in veterinary cardiology are key drivers of market expansion across all regions.

Market Dynamics:

Driver:

Growing pet population and increasing prevalence of cardiac diseases

The rising global pet population and increasing prevalence of cardiac conditions, particularly in aging companion animals, are primary drivers for the veterinary cardiology market. As pets live longer due to improved nutrition and healthcare, age-related cardiac diseases including valvular disease and cardiomyopathy are becoming more common. Small breed dogs are particularly susceptible to mitral valve disease, while certain large breeds face higher cardiomyopathy risk. Veterinary cardiology diagnostics and treatments are increasingly sought as pet owners become more aware of cardiac health signs. The growing demand for advanced cardiovascular care, including echocardiography, electrocardiography, and interventional procedures, supports sustained market expansion across all practice types.

Restraint:

High cost of cardiac diagnostic equipment and procedures

The significant costs associated with veterinary cardiology equipment and specialized procedures represent a major restraint for the market. Advanced diagnostic systems including echocardiography machines, cardiac monitors, and interventional equipment require substantial capital investment. Specialized cardiac procedures including pacemaker implantation, valve repair, and interventional catheterization are expensive. Smaller practices may struggle to justify investment in specialized cardiology equipment. Limited insurance coverage for cardiac procedures affects affordability for pet owners. These cost barriers may limit access to advanced cardiac care, particularly for smaller practices and in regions with lower disposable incomes.

Opportunity:

Advancements in veterinary interventional cardiology

Continuous innovation in interventional cardiology procedures and devices presents significant opportunities for market expansion. Minimally invasive procedures including balloon valvuloplasty, stent placement, and pacemaker implantation are becoming more available in veterinary practice. Advanced catheterization techniques are enabling treatment of complex cardiac conditions. Transcatheter valve replacement technologies are being adapted for veterinary use. Advancements in cardiac implantable electronic devices are expanding treatment options. As interventional capabilities expand and equipment becomes more accessible, new treatment options capture growing market share, enabling enhanced patient outcomes and practice growth.

Threat:

Shortage of veterinary cardiology specialists

The limited availability of board-certified veterinary cardiologists and specialized cardiac technicians poses a significant threat to the market. Veterinary cardiology procedures require specialized training, diagnostic interpretation skills, and surgical expertise that may not be available in general practice. Academic training programs may not produce sufficient specialists to meet growing demand. Referral to specialty centers may be geographically inaccessible for many pet owners. The shortage of specialists may lead to longer wait times, increased costs, and reduced procedure volumes. This workforce constraint may limit market growth and accessibility, particularly in underserved regions.

Covid-19 Impact:

The COVID-19 pandemic had a significant impact on the veterinary cardiology market. Initial disruptions included reduced veterinary visits, postponement of non-urgent cardiac procedures, and supply chain interruptions. Telemedicine consultations for cardiac evaluations expanded during lockdowns. Veterinary practices adapted with enhanced infection control protocols. Post-pandemic, pet ownership and veterinary visits rebounded, with increased awareness of pet health and well-being. The crisis reinforced the importance of specialty veterinary care and accelerated adoption of remote monitoring technologies. As pet owners prioritize their animals' health, demand for advanced cardiac care continues growing.

The Veterinary Hospitals segment is expected to be the largest during the forecast period

The Veterinary Hospitals segment is expected to account for the largest market share during the forecast period, driven by the comprehensive cardiology services offered by larger veterinary hospitals and their capacity to accommodate advanced diagnostic equipment and specialized procedures. Veterinary hospitals have the infrastructure and case volumes to justify investment in echocardiography systems, cardiac monitors, and interventional equipment. The segment benefits from referral networks with general practices and growing demand for advanced cardiac care. Established cardiology services and specialist presence support patient volume. As veterinary hospitals expand cardiology services and specialty care becomes more accessible, this end-user segment maintains the largest market share throughout the forecast period.

The Online Sales segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Online Sales segment is predicted to witness the highest growth rate, fueled by the growing adoption of e-commerce platforms for veterinary equipment purchasing and increasing availability of cardiology products through digital channels. Online sales offer convenience, competitive pricing, and expanded product selection for veterinary practices. The segment benefits from growing digital literacy among veterinary professionals and increasing acceptance of online purchasing for medical equipment and supplies. Direct-to-consumer online sales of cardiac monitoring devices and supplements are expanding. As e-commerce infrastructure improves and veterinary purchasing habits evolve, online sales deliver the fastest sales channel segment growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, strong spending on veterinary specialty care, and advanced veterinary healthcare infrastructure. The United States leads regional market growth with substantial investment in veterinary cardiology services and equipment. High awareness of cardiac conditions and treatment options supports procedure volumes. Strong presence of veterinary cardiology specialists, referral centers, and equipment manufacturers drives innovation. Established pet insurance adoption supports affordability. With high pet spending and advanced veterinary infrastructure, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising pet ownership, increasing disposable incomes, and growing awareness of advanced veterinary care across countries including China, India, Australia, and Southeast Asia. The region's rapidly growing pet population and expanding middle class create substantial demand for veterinary specialty services. Veterinary practice modernization and technology adoption are accelerating. Growing investment in veterinary education and specialist training is expanding cardiology capabilities. Increasing pet insurance adoption supports affordability. As veterinary healthcare develops and specialty services expand, Asia Pacific delivers the fastest veterinary cardiology market growth globally.

Key players in the market

Some of the key players in Veterinary Cardiology Market include IDEXX Laboratories, Inc., Zoetis Inc., FUJIFILM Sonosite, Inc., Esaote S.p.A., GE HealthCare, Siemens Healthineers AG, Bionet Co., Ltd., Mindray Medical International Limited, Butterfly Network, Inc., Heska Corporation, Antech Diagnostics, Virbac S.A., Boehringer Ingelheim Animal Health, Ceva Sante Animale, Jurox Pty Ltd., and Scil Animal Care Company GmbH.

Key Developments:

In March 2026, Esaote Group showcased its MyLab(TM)E85 GTS and MyLab(TM)C30 GTS Edition ultrasound systems at ECR 2026, integrating real-time multimodality fusion imaging, contrast-enhanced modes, and shear-wave elastography for advanced diagnostic and interventional guidance.

In March 2026, Esaote Group showcased its MyLab(TM)E85 GTS and MyLab(TM)C30 GTS Edition ultrasound systems at ECR 2026, integrating real-time multimodality fusion imaging, contrast-enhanced modes, and shear-wave elastography for advanced diagnostic and interventional guidance.

In January 2026, Boehringer Ingelheim received full approval from the U.S. Food and Drug Administration (FDA) for VETMEDIN(R) (pimobendan) Chewable Tablets and Oral Solution to delay the onset of congestive heart failure (CHF) in dogs with preclinical myxomatous mitral valve disease.

In October 2025, Butterfly Network commercially launched its next-generation Butterfly iQ3 Vet(TM) handheld point-of-care ultrasound solution in the United States and Canada, leveraging Ultrasound-on-Chip(TM) semiconductor technology to enhance cardiac and abdominal imaging capabilities for veterinary clinicians.

Products Covered:

• Diagnostic Equipment
• Therapeutics
• Monitoring and Accessories

Animal Types Covered:

• Dogs
• Cats
• Horses
• Other Companion Animals

Indications Covered:

• Congestive Heart Failure
• Valvular Heart Disease
• Dilated Cardiomyopathy
• Hypertrophic Cardiomyopathy
• Congenital Heart Diseases
• Cardiac Arrhythmias
• Pulmonary Hypertension
• Other Cardiovascular Disorders

Diagnosis Methods Covered:

• Electrocardiography (ECG)
• Echocardiography
• Radiography
• Cardiac Biomarker Testing
• Blood Pressure Monitoring
• CT and MRI
• Other Diagnostic Methods

Treatment Types Covered:

• Medical Management
• Interventional Procedures
• Surgical Procedures
• Long-Term Monitoring

Applications Covered:

• Diagnosis
• Disease Monitoring
• Therapeutic Management
• Preventive Cardiac Screening

End Users Covered:

• Veterinary Hospitals
• Veterinary Clinics
• Specialty Cardiology Centers
• Veterinary Academic and Research Institutes

Sales Channels Covered:

• Direct Sales
• Distributors
• Online Sales
• Group Purchasing Organizations

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Veterinary Cardiology Market, By Product

• 5.1 Diagnostic Equipment
  • 5.1.1 Electrocardiography (ECG) Systems
  • 5.1.2 Echocardiography Systems
  • 5.1.3 Holter Monitoring Systems
  • 5.1.4 Blood Pressure Monitoring Systems
  • 5.1.5 Cardiac Biomarker Testing Kits
• 5.2 Therapeutics
  • 5.2.1 Cardiac Drugs
  • 5.2.2 Interventional Devices
• 5.3 Monitoring and Accessories

6 Global Veterinary Cardiology Market, By Animal Type

• 6.1 Dogs
• 6.2 Cats
• 6.3 Horses
• 6.4 Other Companion Animals

7 Global Veterinary Cardiology Market, By Indication

• 7.1 Congestive Heart Failure
• 7.2 Valvular Heart Disease
• 7.3 Dilated Cardiomyopathy
• 7.4 Hypertrophic Cardiomyopathy
• 7.5 Congenital Heart Diseases
• 7.6 Cardiac Arrhythmias
• 7.7 Pulmonary Hypertension
• 7.8 Other Cardiovascular Disorders

8 Global Veterinary Cardiology Market, By Diagnosis Method

• 8.1 Electrocardiography (ECG)
• 8.2 Echocardiography
• 8.3 Radiography
• 8.4 Cardiac Biomarker Testing
• 8.5 Blood Pressure Monitoring
• 8.6 CT and MRI
• 8.7 Other Diagnostic Methods

9 Global Veterinary Cardiology Market, By Treatment Type

• 9.1 Medical Management
• 9.2 Interventional Procedures
• 9.3 Surgical Procedures
• 9.4 Long-Term Monitoring

10 Global Veterinary Cardiology Market, By Application

• 10.1 Diagnosis
• 10.2 Disease Monitoring
• 10.3 Therapeutic Management
• 10.4 Preventive Cardiac Screening

11 Global Veterinary Cardiology Market, By End User

• 11.1 Veterinary Hospitals
• 11.2 Veterinary Clinics
• 11.3 Specialty Cardiology Centers
• 11.4 Veterinary Academic and Research Institutes

12 Global Veterinary Cardiology Market, By Sales Channel

• 12.1 Direct Sales
• 12.2 Distributors
• 12.3 Online Sales
• 12.4 Group Purchasing Organizations

13 Global Veterinary Cardiology Market, By Geography

• 13.1 North America
  • 13.1.1 United States
  • 13.1.2 Canada
  • 13.1.3 Mexico
• 13.2 Europe
  • 13.2.1 United Kingdom
  • 13.2.2 Germany
  • 13.2.3 France
  • 13.2.4 Italy
  • 13.2.5 Spain
  • 13.2.6 Netherlands
  • 13.2.7 Belgium
  • 13.2.8 Sweden
  • 13.2.9 Switzerland
  • 13.2.10 Poland
  • 13.2.11 Rest of Europe
• 13.3 Asia Pacific
  • 13.3.1 China
  • 13.3.2 Japan
  • 13.3.3 India
  • 13.3.4 South Korea
  • 13.3.5 Australia
  • 13.3.6 Indonesia
  • 13.3.7 Thailand
  • 13.3.8 Malaysia
  • 13.3.9 Singapore
  • 13.3.10 Vietnam
  • 13.3.11 Rest of Asia Pacific
• 13.4 South America
  • 13.4.1 Brazil
  • 13.4.2 Argentina
  • 13.4.3 Colombia
  • 13.4.4 Chile
  • 13.4.5 Peru
  • 13.4.6 Rest of South America
• 13.5 Rest of the World (RoW)
  • 13.5.1 Middle East
    • 13.5.1.1 Saudi Arabia
    • 13.5.1.2 United Arab Emirates
    • 13.5.1.3 Qatar
    • 13.5.1.4 Israel
    • 13.5.1.5 Rest of Middle East
  • 13.5.2 Africa
    • 13.5.2.1 South Africa
    • 13.5.2.2 Egypt
    • 13.5.2.3 Morocco
    • 13.5.2.4 Rest of Africa

14 Strategic Market Intelligence

• 14.1 Industry Value Network and Supply Chain Assessment
• 14.2 White-Space and Opportunity Mapping
• 14.3 Product Evolution and Market Life Cycle Analysis
• 14.4 Channel, Distributor, and Go-to-Market Assessment

15 Industry Developments and Strategic Initiatives

• 15.1 Mergers and Acquisitions
• 15.2 Partnerships, Alliances, and Joint Ventures
• 15.3 New Product Launches and Certifications
• 15.4 Capacity Expansion and Investments
• 15.5 Other Strategic Initiatives

16 Company Profiles

• 16.1 IDEXX Laboratories, Inc.
• 16.2 Zoetis Inc.
• 16.3 FUJIFILM Sonosite, Inc.
• 16.4 Esaote S.p.A.
• 16.5 GE HealthCare
• 16.6 Siemens Healthineers AG
• 16.7 Bionet Co., Ltd.
• 16.8 Mindray Medical International Limited
• 16.9 Butterfly Network, Inc.
• 16.10 Heska Corporation
• 16.11 Antech Diagnostics
• 16.12 Virbac S.A.
• 16.13 Boehringer Ingelheim Animal Health
• 16.14 Ceva Sante Animale
• 16.15 Jurox Pty Ltd.
• 16.16 Scil Animal Care Company GmbH